300858.SZ Stock Analysis
30
Neutral
Based on Eyestock quantitative analysis, 300858.SZ`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Overvalued
Beijing Scitop Bio-Tech Co., Ltd. develops, produces, and sells probiotic lactic acid bacteria and related products and provides a complete set of product solutions. The company is headquartered in Beijing, Beijing and currently employs 226 full-time employees. The company went IPO on 2020-07-27. The firm's main products include compound food additives, edible probiotic products, animal and plant microecological preparations and others. The firm mainly conducts its businesses within the China market.